Brain Cancer Biobanking Australia (BCBA) is a virtual biobank hub established to provide researchers easy access to the amount, quality and type of tissue and associated data they need to accelerate both paediatric and adult translational brain cancer research.
BCBA consortium member, Associate Professor David Ziegler has big plans for 2021. The paediatric oncologist at Sydney Children’s Hospital, Randwick, is expanding the Zero Childhood Cancer program, with the aim to offer complete tumour sequencing for every childhood brain cancer patient in the country. The program has so far identified the genetic basis of a child’s cancer in more than 90 per cent of cases, giving 70 per cent of participants at least one new potential treatment option.
Ziegler has been spearheading the program since it began with a local pilot in 2016. His interest in paediatric oncology was sparked early in his career, and he continues to be motivated by seeing his patients respond to a new treatment his team has developed.
David was drawn to commitment of the BCBA to inspire the best research and build productive networks,
“What I love about BCBA is that no problem is too large and nothing is impossible – obstacles are viewed as challenges that must be overcome and the focus is always on the endgame and the patients who need the investment of research and discovery”.
Against all the odds the Bike Ride for Brain Cancer (BRBC) went ahead on 19th and 20th March, with a dedicated group of 56 riders managing to complete 100kms of the 250km course despite the extreme weather conditions in NSW. The BRBC is the major fundraising event of BCBA’s charity arm, the Brain Cancer Collective. After being Covided out in 2020, the riders were more than ready to hit the road in 2021 to raise awareness of brain cancer and approximately $300,000 in funds to support the important work of BCBA.
The spirit of the event is captured in this short video.